First human test: how do failing kidneys handle a new drug?
NCT ID NCT06723535
Summary
This early-stage study tested how a single dose of an experimental drug, BMS-986278, is processed by the body in people with different levels of kidney function. It involved 27 participants, including healthy volunteers and people with severe kidney disease or kidney failure requiring dialysis. The main goal was to see if kidney problems change how the drug behaves in the body and to check for any safety issues.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution - 0002
Miami, Florida, 33147-4040, United States
-
Local Institution - 0003
Miami, Florida, 33172, United States
-
Local Institution - 0004
Orlando, Florida, 32808-7820, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32809-3017, United States
Conditions
Explore the condition pages connected to this study.